Evgen Pharma granted first European patent for SFX-01
Clinical-stage drug development company Evgen Pharma announced the grant of the first European patent for SFX-01, its lead product, on Wednesday.
Clinical-stage drug development company Evgen Pharma announced the grant of the first European patent for SFX-01, its lead product, on Wednesday.